We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+8.9%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.03B
AUM Growth
+$187M
Cap. Flow
-$36.9M
Cap. Flow %
-1.22%
Top 10 Hldgs %
42.25%
Holding
227
New
13
Increased
20
Reduced
107
Closed
9

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$20M
2
CACC icon
Credit Acceptance
CACC
+$5.03M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.83M
4
EPD icon
Enterprise Products Partners
EPD
+$4.42M
5
SPB icon
Spectrum Brands
SPB
+$3.69M

Top Sells

Rank Stock Value
1
MTDR icon
Matador Resources
MTDR
+$8.98M
2
LUMN icon
Lumen
LUMN
+$7.82M
3
MSFT icon
Microsoft
MSFT
+$4.81M
4
GILD icon
Gilead Sciences
GILD
+$3.48M
5
AWI icon
Armstrong World Industries
AWI
+$3.11M

Sector Composition

Rank Sector Weight
1 Financials 35.15%
2 Healthcare 15.99%
3 Technology 12.78%
4 Communication Services 9.38%
5 Industrials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DISCK
26
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$41.5M 1.37%
1,361,846
-1,830
-0.1% -$51.3K
UNP icon
27
Union Pacific
UNP
$174B
$41.1M 1.36%
227,504
-1,958
-0.9% -$335K
BN icon
28
Brookfield
BN
$102B
$40.6M 1.34%
1,969,550
-43,849
-2% -$874K
AXP icon
29
American Express
AXP
$224B
$39.5M 1.31%
317,551
-23,130
-7% -$2.76M
BAX icon
30
Baxter International
BAX
$12.8B
$38.8M 1.28%
463,780
-10,860
-2% -$899K
WMS icon
31
Advanced Drainage Systems
WMS
$10.6B
$37.4M 1.24%
963,277
-665
-0.1% -$24.6K
TEVA icon
32
Teva Pharmaceuticals
TEVA
$40.4B
$29M 0.96%
2,954,140
+540,718
+22% +$4.83M
GRFS
33
Grifois
GRFS
$5.55B
$27M 0.89%
1,161,304
-24,652
-2% -$537K
LOW icon
34
Lowe's Companies
LOW
$121B
$26.5M 0.88%
221,151
-5,600
-2% -$640K
DOV icon
35
Dover
DOV
$26.7B
$25.9M 0.85%
224,426
-14,778
-6% -$1.58M
BB icon
36
BlackBerry
BB
$4.58B
$24.6M 0.81%
3,832,822
+99,392
+3% +$546K
VZ icon
37
Verizon
VZ
$197B
$22.2M 0.73%
362,051
-5,649
-2% -$341K
RDNT icon
38
RadNet
RDNT
$4.98B
$21.6M 0.71%
1,062,619
-4,420
-0.4% -$75.8K
SYY icon
39
Sysco
SYY
$40.8B
$19.3M 0.64%
225,538
-3,410
-1% -$276K
USB icon
40
US Bancorp
USB
$97.9B
$19M 0.63%
319,930
-6,562
-2% -$379K
GILD icon
41
Gilead Sciences
GILD
$165B
$18.9M 0.62%
290,711
-53,507
-16% -$3.48M
ENB icon
42
Enbridge
ENB
$120B
$18.6M 0.62%
468,305
-15,030
-3% -$561K
MRK icon
43
Merck
MRK
$322B
$18.2M 0.6%
209,236
-6,120
-3% -$503K
WMT icon
44
Walmart Inc
WMT
$909B
$16.6M 0.55%
420,006
-8,250
-2% -$328K
DUK icon
45
Duke Energy
DUK
$101B
$14.9M 0.49%
163,509
-100
-0.1% -$9.17K
WMB icon
46
Williams Companies
WMB
$85.8B
$12.6M 0.42%
530,629
-14,900
-3% -$341K
FDX icon
47
FedEx
FDX
$73B
$11.6M 0.38%
76,728
-10,543
-12% -$1.62M
AAPL icon
48
Apple
AAPL
$4.97T
$11.2M 0.37%
152,736
-400
-0.3% -$25.7K
HUBB icon
49
Hubbell
HUBB
$24.4B
$11M 0.36%
74,720
-1,393
-2% -$198K
XOM icon
50
ExxonMobil
XOM
$650B
$11M 0.36%
156,949
-4,974
-3% -$344K
1
2
3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2019 Portfolio in Review

As of Q4 2019, Beck Mack & Oliver held 227 positions worth $3.03B, up 6.6% from $2.84B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Beck Mack & Oliver's Q4 2019 filing shows 13 new, 20 increased, 107 reduced and 9 closed positions. Its largest new stake was Spectrum Brands: 65,201 shares worth $4.19M. The largest sale was Matador Resources, an estimated $8.98M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q4 2019 buy was Spectrum Brands: 65,201 shares worth $4.19M.
  • Beck Mack & Oliver added most to Charles Schwab in Q4 2019, an estimated $20M increase.
  • Beck Mack & Oliver's biggest Q4 2019 reduction was Matador Resources, cutting an estimated $8.98M.
  • Beck Mack & Oliver fully exited Celgene Corp in Q4 2019, selling an estimated $679K.
  • Beck Mack & Oliver's ten largest holdings make up 42% of its $3.03B portfolio in Q4 2019.
  • Beck Mack & Oliver opened 13 new positions and closed 9 in Q4 2019.
  • Beck Mack & Oliver's portfolio value rose 6.6% quarter-over-quarter to $3.03B.

Based on Beck Mack & Oliver's 13F filing for Q4 2019, filed 7 Feb 2020.